MedTrace Logo

Long-term Sedation With Remimazolam Besylate in Critically Ill Patients

NCT05555667 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 728

Last updated 2023-05-26

No results posted yet for this study

Summary

A randomized non-inferior trial comparing remimazolam besylate with propofol for long-term sedation during invasive mechanical ventilation in critically ill patients

Conditions

  • Light Sedation
  • Mechanical Ventilation

Interventions

DRUG

Remimazolam besylate

Sedation drug

DRUG

Propofol

Propofol. Sedation drug

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-16
Primary Completion
2025-11-01
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05555667 on ClinicalTrials.gov